A Mass Spectrometry Approach to the Genetic and Epigenetic Mechanisms Controlling Neuronal Identity
控制神经元身份的遗传和表观遗传机制的质谱方法
基本信息
- 批准号:10561685
- 负责人:
- 金额:$ 51.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAcetylationAdultAffectBindingBrainBrain DiseasesBrain regionCatalytic DomainCell Differentiation processCell Fate ControlCell LineageCell SeparationCellsCerebellumChIP-seqChromatinChromatin Remodeling FactorCo-ImmunoprecipitationsCognitiveCollaborationsComplexCorpus CallosumCoupledDNA BindingDataDefectDevelopmentDevelopmental BiologyDiagnosisEmbryoEpigenetic ProcessEpilepsyFutureGene ExpressionGene TargetingGenesGeneticGenetic TranscriptionGlobal ChangeGrantGrowthHistonesHumanImmunoprecipitationIn VitroIntellectual functioning disabilityLeadLifeLinkMaintenanceMalignant neoplasm of brainMapsMass Spectrum AnalysisMedicineMental RetardationMethylationMicrocephalyMolecular AnalysisMotorMusMutationNeocortexNeurodegenerative DisordersNeurologicNeuronal DifferentiationNeuronsNucleosomesPennsylvaniaPolycombPost-Translational Protein ProcessingProcessProliferatingProteinsProteomicsRegulationSWI/SNF Family ComplexSchizophreniaTestingTherapeutic InterventionTissuesUniversitiesWestern BlottingZinc Fingersbrain malformationcell typedevelopmental neurobiologydisabilityepigenetic regulationexperimental studygene repressionin vivoinsightlife-long learningloss of functionmembermouse geneticsneocorticalnervous system disorderneurogenesispostmitoticpostnatalprogenitorprogramsprotein protein interactiontranscription factortranscriptome
项目摘要
Abstract
Deciphering the mechanisms controlling cell fate choice and maintenance in the brain is a critical step in
understanding devastating neurological disorders such as microcephaly, schizophrenia and brain cancer that
result from defects in these processes. An unresolved question is how the mammalian neuronal identity is
maintained and protected, particularly at the transcriptional level, during development and adult life. The
BTB/POZ and Zinc finger transcription factor RP58 (aka ZBTB18), is required for brain development and
neuronal differentiation both in vivo and in vitro; Mutations in RP58 are linked to human microcephaly and corpus
callosum agenesis. We have analyzed the embryonic cortical post mitotic neurons’ transcriptome and showed
that the expression of gene markers of other cell lineages, such as myogenic lineage, is increased following
Rp58 deletion suggesting that RP58 protects the neuronal identity by repressing genes of other lineages. Our
overall hypothesis is that RP58 is required to establish and maintain the neuronal identity and that the loss of its
transcriptional function may lead to microcephaly and to neurodegenerative diseases in the adult brain. To
decipher how RP58 controls cell differentiation in the brain and to identify RP58 protein partners that may be
involved in its function, we have performed RP58 immunoprecipitation coupled to mass spectrometry (IP-MS)
experiments on mouse embryonic and postnatal cortices. Our data show that RP58 binds to members of both
the Polycomb Repressive Complex 2 (PRC2) and the SWI/SNF complex, two critical chromatin remodeling
complexes involved in brain development. In addition, using quantitative histone proteomics and western blot
analyses, we show that deletion of Rp58 in the embryonic brain leads to global changes in histones post-
translational modifications (PTMs) including to decreased H3K27 methylation (H3K27me) and increased
H3K9/14 acetylation. These results raise the hypothesis that RP58 controls the identity of developing and adult
neurons and thus their transcriptional program by modulating the PRC2 and SWI/SNF complexes function and
the chromatin landscape.
The following aims will address these hypotheses. Aim 1: Decipher how RP58 and chromatin remodeling
complexes interact to establish and maintain neuronal identity. Aim 2: Decipher if and how RP58 is required for
histone PTMs in neural cells. Aim 3: Determine the cell and developmental stage-specific RP58 protein-protein
interacting network in neural cells. This grant is a collaboration between the Dahmane lab (Weill Cornell
Medicine) with expertise in developmental neurobiology and mouse genetics and the Garcia lab (University of
Pennsylvania) with expertise in quantitative mass spectrometry as it relates to epigenetic mechanisms and
chromatin regulation. Completion of these proposed studies will lead to the elucidation of the cell type and stage
specific RP58 regulatory mechanisms controlling neuronal identity and to key insights into the genetic and
epigenetic regulation of brain growth and of their misregulation in brain disorders such as microcephaly.
抽象的
破译大脑中控制细胞命运选择和维持的机制是关键一步
了解神经系统疾病,例如小头畸形、精神分裂症和脑癌
这些过程中的缺陷导致的一个未解决的问题是哺乳动物的神经身份是如何的。
在发育和成年期间维持和保护,特别是在转录水平上。
BTB/POZ 和锌指转录因子 RP58(又名 ZBTB18)是大脑发育和
体内和体外的神经元分化;RP58 突变与人类小头畸形和小体畸形有关;
我们分析了胚胎皮质有丝分裂后神经元的转录组并显示。
其他细胞谱系(例如肌源性谱系)的基因标记的表达在以下情况下增加
Rp58 缺失表明 RP58 通过抑制其他谱系的基因来保护神经元身份。
总体假设是 RP58 是建立和维持神经同一性所必需的,并且其丧失
转录功能可能导致成人大脑中的小头畸形和神经退行性疾病。
破译 RP58 如何控制大脑中的细胞分化,并确定可能的 RP58 蛋白伴侣
为了了解其功能,我们进行了 RP58 免疫沉淀偶联质谱 (IP-MS)
我们的数据表明,RP58 与小鼠胚胎和出生后皮质的成员结合。
Polycomb 抑制复合体 2 (PRC2) 和 SWI/SNF 复合体,两个关键的染色质重塑
此外,使用定量组蛋白蛋白质组学和蛋白质印迹。
分析表明,胚胎大脑中 Rp58 的缺失会导致组蛋白的整体变化。
翻译修饰 (PTM) 包括降低 H3K27 甲基化 (H3K27me) 和增加
这些结果提出了 RP58 控制发育和成人身份的假设。
神经元及其转录程序通过调节 PRC2 和 SWI/SNF 复合物的功能和
染色质景观。
以下目标将解决这些假设 目标 1:破译 RP58 和染色质重塑的方式。
复合物相互作用以建立和维持神经同一性 目标 2:破译 RP58 是否需要以及如何需要。
神经细胞中的组蛋白 PTM 目标 3:确定细胞和发育阶段特异性 RP58 蛋白。
神经细胞中的相互作用网络这项资助是达赫曼实验室(威尔康奈尔大学)之间的合作。
医学)拥有发育神经生物学和小鼠遗传学方面的专业知识,加西亚实验室(University of
宾夕法尼亚州)拥有定量质谱方面的专业知识,因为它与表观遗传机制有关
完成这些拟议的研究将有助于阐明细胞类型和阶段。
控制神经身份的特定 RP58 调节机制以及对遗传和遗传的关键见解
大脑生长的表观遗传调控及其在小头畸形等大脑疾病中的失调。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nadia Dahmane其他文献
Nadia Dahmane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nadia Dahmane', 18)}}的其他基金
Deciphering the 3D genome of pediatric brain tumors
破译儿童脑肿瘤的 3D 基因组
- 批准号:
10585741 - 财政年份:2022
- 资助金额:
$ 51.54万 - 项目类别:
A Mass Spectrometry Approach to the Genetic and Epigenetic Mechanisms Controlling Neuronal Identity
控制神经元身份的遗传和表观遗传机制的质谱方法
- 批准号:
10339433 - 财政年份:2020
- 资助金额:
$ 51.54万 - 项目类别:
Inhibitors of Hedgehog Signaling For Brain Cancer Chemotherapy
脑癌化疗的 Hedgehog 信号抑制剂
- 批准号:
7654776 - 财政年份:2009
- 资助金额:
$ 51.54万 - 项目类别:
相似国自然基金
β-羟丁酸介导DUOX1/DUOXA1组蛋白乙酰化增强鼻咽癌放疗敏感性
- 批准号:82360509
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
脂肪酸β氧化介导ALKBH5乙酰化促进三阴性乳腺癌干细胞免疫逃逸的作用及机制研究
- 批准号:82373088
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
KAT8上调组蛋白H3乙酰化修饰水平促进中性粒细胞胞外诱捕网形成介导ARDS进展的机制研究
- 批准号:82360374
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
阻断TRPV4通过抑制线粒体内PDHE1α乙酰化减少心衰后恶性室性心律失常的发生的机制研究
- 批准号:82370329
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ADAMTSL3调控p53乙酰化介导的肾小管上皮细胞衰老引起AKI慢性化的机制研究
- 批准号:82360139
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
- 批准号:
10752404 - 财政年份:2023
- 资助金额:
$ 51.54万 - 项目类别:
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
- 批准号:
10577265 - 财政年份:2023
- 资助金额:
$ 51.54万 - 项目类别:
Role of neonatal lung macrophages in mediating resilience to hyperoxia induced lung injury via TREM2 signaling
新生儿肺巨噬细胞通过 TREM2 信号传导介导高氧诱导肺损伤的恢复能力
- 批准号:
10720557 - 财政年份:2023
- 资助金额:
$ 51.54万 - 项目类别:
Connectivity mapping identified novel combination therapy for glioblastoma
连接映射确定了胶质母细胞瘤的新型联合疗法
- 批准号:
10686268 - 财政年份:2022
- 资助金额:
$ 51.54万 - 项目类别: